Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Qing-Yun Zhang
LAPTM4B Is a Novel Diagnostic and Prognostic Marker for Lung Adenocarcinoma and Associated With Mutant EGFR
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients
Tumor Biology
Medicine
Cancer Research
Apolipoprotein C1 (APOC1) as a Novel Diagnostic and Prognostic Biomarker for Lung Cancer: A Marker Phase I Trial
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Volume-Based Growth Tumor Kinetics as a Prognostic Biomarker for Patients With EGFR Mutant Lung Adenocarcinoma Undergoing EGFR Tyrosine Kinase Inhibitor Therapy: A Case Control Study
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients
Oncology Reports
Medicine
Cancer Research
Oncology
2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma
Journal of Clinical and Translational Science
Medicine
A Case of Small Cell Lung Cancer Transformation From EGFR-Mutant Lung Adenocarcinoma With Primary Resistance to Gefitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Can We Omit Radiotherapy in Case of Brain Metastases for Patients With Mutant EGFR Lung Adenocarcinoma?
Translational Lung Cancer Research
Oncology
P3.16-03 Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
